Sudden death in a patient with tourette syndrome during a clinical trial of ziprasidone

Journal of Psychopharmacology

Volumn 19, Issue 2, 2005, Pages 205-206

  Scahill, Lawrence ^a,b   Blair, Jennifer ^a   Leckman, James F ^b   Martin, Andrés ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLONAZEPAM; CLONIDINE; HALOPERIDOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NAPROXEN; NEUROLEPTIC AGENT; RISPERIDONE; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

ADULT; ARTICLE; AUTOPSY; BODY WEIGHT; CASE REPORT; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ELECTROCARDIOGRAM; FOOD AND DRUG ADMINISTRATION; GILLES DE LA TOURETTE SYNDROME; HEART ARRHYTHMIA; HUMAN; MALE; OPEN STUDY; PAIN; PRIORITY JOURNAL; QT PROLONGATION; RATING SCALE; SEDATION; SIDE EFFECT; SLEEP DISORDER; SUDDEN DEATH; TIC; TREATMENT OUTCOME; WEIGHT GAIN; YALE GLOBAL TIC SEVERITY SCALE;

ADULT; ANTIPSYCHOTIC AGENTS; CHOLESTEROL; DEATH, SUDDEN; FATAL OUTCOME; HUMANS; MALE; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; THIAZOLES; TOURETTE SYNDROME;

EID: 17744399085     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105049042     Document Type: Article

References (10)

1. Blair J, Scahill L, State M, Martin A (2005) Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study. J Am Acad Child Adolesc Psychiatry, in press
2. Blair J, Taggart B, Martin A (2004) Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology. J Neural Transm 111: 791-815
3. Geodon (ziprasidone) (2002) Package insert: available at: http://www. pfizer.com/download/uspi_geodon.pdf (accessed 2 April 2004)
4. Morganroth J, Brozovich F V, McDonald J T, Jacobs R A (1991) Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. Am J Cardiol 67: 774-776
5. NHANES (2004a) National Health and Nutrition Examination Survey. Body mass (kilograms divided by height in meters squared) index for males 20 years and over - number of examined persons, mean, standard error of the mean, and selected percentiles, by race, ethnicity, and age: United States, 1988-1994. [CDC NHANES III website.] Available at: http://www.cdc.gov/nchs/data/nhanes/t8. pdf (accessed 5 April 2004)
6. NHANES III (2004b) National Health and Nutrition Examination Survey. Serum high density lipoprotein (HDL) cholesterol of males 4 years of age and older by age: mean and selected percentiles, United States, 1988-1994. [CDC NHANES III website.] Available at: http://www.cdc. gov/nchs/data/nhanes/hdlmale. pdf (accessed 2 April 2004)
7. Sallee F R, Kurlan R, Goetz C G, Singer H, Scahill L, Law G, Dittman V M, Chappell P B (2000) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 39: 292-299
8. Schmidt A W, Lebel L A, Howard H R Jr, Zorn S H (2001) Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile. Eur J Pharmacol 425: 197-201
9. Varley C K (2001) Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications. Paediatr Drugs 3: 613-627
10. Witchel H, Hancox J, Nutt D (2003) Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol 23: 58-77